Organ trading involves the commercial exchange of organs (and their accompanying tissue structures) to provide sufficient numbers of healthy organs for transplantation procedures. Although essentially any organ in the body can be eligible for transplantation, the dominant organs are the kidneys, the heart, and the liver. In the age of cutting-edge medical technologies that, since the 1990s, have entirely revolutionized the surgical protocols for replacing damaged organs through transplantation to the point where such procedures, once considered highly risky and rare, have become among the most commonly performed surgeries in the world, the organ trade has emerged as one of the most hotly debated issues in bioethics. The problem is a question of free market dynamics and elemental economics: the demand is greater than the supply, as those who need healthy organs far outnumber those willing to donate organs.